TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has provided an update.
ResMed Inc., a company known for its medical equipment and software solutions, has reported changes in beneficial ownership involving its director, Nicole Mowad-Nassar. The transaction involved the acquisition of 1,331 stock options at a price of $250.52, which will become exercisable by November 11, 2026, or earlier depending on the company’s annual meeting schedule. This transaction reflects strategic stock management and could influence stakeholder perceptions regarding the company’s governance and future performance.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$42.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
Average Trading Volume: 1,226,132
Technical Sentiment Signal: Buy
Current Market Cap: A$57.53B
See more insights into RMD stock on TipRanks’ Stock Analysis page.